Anthony Fauci, M.D., National Institute of Allergy and Infectious Diseases Director and Moncef Slaoui, Ph.D., U.S. Operation Warp Speed Chief Advisor will speak on a special plenary session on Tuesday, June 9 during BIO Digital, a virtual conference hosted by the Biotechnology Innovation Organization (BIO) running June 8-12. Newly appointed BIO President & Chief Executive Officer Michelle McMurry-Heath, M.D., Ph.D., joins BIO Chairman of the Board Jeremy Levin, and outgoing Chief Executive Officer and industry champion Jim Greenwood to kick-off four days of discussions on how the biotech sector is rising to meet the greatest public health challenge in a century. “I look forward to hearing from those leading the way to accelerate progress against this global pandemic, as well as other pressing issues as we gather virtually,” said McMurry-Heath. “We are inspired by the continued collaboration of biotechnology and pharma companies and look forward to BIO Digital 2020 revealing even more from innovators working to combat COVID-19 and leading health issues.” New programming reflects a heightened focus on COVID-19 highlighting vaccine development, clinical trials, innovative collaborations and technologies to combat the pandemic. A three-part plenary, sponsored by Johnson & Johnson, will feature notable speakers exploring the swift response from the industry to develop a vaccine against an unknown pathogen while facing challenges of manufacturing scale-up and global implementation. COVID-19 plenary sessions will be aired later, free of cost to the public. The BIO Digital agenda includes at least 50 live and interactive sessions with an additional 60 on-demand sessions and over 250 company presentations focused on the leading industry topics and company pipelines. Beyond COVID-19, sessions will cover digital health, infectious diseases, cell and gene therapies, business development and finance, oncology, and more on the latest therapeutic advancements in…